Company profile: ElsaLys Biotech
1.1 - Company Overview
Company description
- Provider of therapeutic monoclonal antibody development, based in Lyon and Illkirch Graffenstaden, France.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ElsaLys Biotech
Mariana Oncology
HQ: United States
Website
- Description: Provider of precision radiopharmaceuticals and radioligand therapeutics for solid tumors, including MC-339 for small cell lung cancer with an actinium-based payload. Offers an integrated discovery and development platform covering target biology, ligand discovery, and optimization, and theranostic approaches using the same ligand for therapy and diagnosis to confirm target engagement, guide patient selection, and optimize dosing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mariana Oncology company profile →
CarThera
HQ: France
Website
- Description: Provider of therapeutic ultrasound-based medical devices for treating brain disorders, including SonoCloud, an intracranial implant that uses low-intensity pulsed ultrasound to temporarily open the blood-brain barrier for enhanced delivery of therapeutic agents, and SonoCloud-9, a nine-emitter version to open larger regions; also conducts preclinical and clinical R&D combining SonoCloud with therapeutic agents to treat brain tumors and neurodegenerative diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CarThera company profile →
NxThera
HQ: United States
Website
- Description: Provider of medical technologies for endourology conditions, including benign prostatic hyperplasia (BPH). The company's minimally invasive vapor therapy platform is designed to measurably improve urinary flow and patient quality of life; BPH affects more than 32 million men in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NxThera company profile →
NanoSmart Pharmaceuticals
HQ: United States
Website
- Description: Provider of platform drug delivery technologies for solid-tumor cancers, including a human-derived Anti-Nuclear Antibody targeting necrotic tumor tissue, ANA-conjugated lipid nanoparticles for direct API delivery to tumor sites, and a thermally sensitive nanoemulsion enabling stable storage and release at body temperature, plus licensing and partnerships to enhance existing cancer drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoSmart Pharmaceuticals company profile →
Theranostics Health
HQ: United States
Website
- Description: Provider of proteomics-based diagnostics and research services for drug development companies, developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor, utilizing Laser Capture Microdissection (LCM) and Reverse-phase Protein MicroArrays (RPMA) assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theranostics Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ElsaLys Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ElsaLys Biotech
2.2 - Growth funds investing in similar companies to ElsaLys Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ElsaLys Biotech
4.2 - Public trading comparable groups for ElsaLys Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →